# Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)

> **NCT00745004** · PHASE4 · COMPLETED · sponsor: **University of Nottingham** · enrollment: 150 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhoea

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00745004
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745004, "Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00745004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*